References
- Worms P. M. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci 2001; 191: 3–9
- Czaplinski A., Yen A. A., Simpson E. P., Appel S. H. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?. Arch Neurol 2006; 63: 1139–43
- Betemps E. J., Buncher C. R. Birthplace as a risk factor in motor neuron disease and Parkinson's disease. Int J Epidemiol 1993; 22: 898–904
- Landtblom A. M., Riise T., Boiko A., Soderfeldt B. Distribution of multiple sclerosis in Sweden based on mortality and disability compensation statistics. Neuroepidemiology 2002; 21: 167–79
- Mandrioli J., Faglioni P., Merelli E., Salo P. The epidemiology of ALS in Modena, Italy. Neurology 2003; 60: 683–9
- Veiga‐Cabo J., Almazan‐Isla J., Sendra‐Gutierrez J. M., de Pedro‐Cuesta J. Differential features of motor neuron disease mortality in Spain. Int J Epidemiol 1997; 26: 1024–32
- Noonan C. W., White M. C., Thurman D., Wong L. Y. Temporal and geographic variation in United States motor neuron disease mortality, 1969–1998. Neurology 2005; 64: 1215–21
- Chancellor A. M., Warlow C. P. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry 1992; 55: 1106–15
- Qureshi M. M., Hayden D., Urbinelli L., Ferrante K., Newhall K., Myers D., et al. Analysis of factors that modify susceptibility and rate of progression in amytrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 2006; 7: 173–82
- Armon A. An evidence‐based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology 2003; 22: 217–28
- Roman G. C. Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis. J Neurol Neurosurg Psychiatry 1996; 61: 131–7
- Chio A. Risk factors in the early diagnosis of ALS: European epidemiological studies. Amyotroph Lateral Sclerosis 2000; 1((Suppl 1))S13–8
- Maasilta P., Jokelainen M., Loytonen M., Sabel C. E., Gatrell A. C. Mortality from amyotrophic lateral sclerosis in Finland, 1986–1995. Acta Neurol Scand 2001; 104: 232–5
- Elian M., Dean G. The changing mortality from motor neuron disease and multiple sclerosis in England and Wales and the Republic of Ireland. Neuroepidemiology 1992; 11: 236–43
- Altavista P., Belli S., Binazzi A., Comba P., Mastrantonio M., Uccelli R., Vanacore N. Increase in mortality for motor neuron disease in Italy, 1980–1999. Epidemiologia e Prevenzione 2006; 30: 108–13
- Neilson S., Robinson I., Alperovitch A. Rising amyotrophic lateral sclerosis mortality in France 1968–1990: increased life expectancy and inter‐disease competition as an explanation. J Neuro 1994; 241: 448–55
- Seljeseth Y. M., Vollset S. E., Tysnes O. B. Increasing mortality from amyotrophic lateral sclerosis in Norway?. Neurology 2000; 55: 1262–6
- Brooks B. R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994; 124((Suppl))96–107
- Meininger V. Getting the diagnosis right: beyond El Escorial. J Neurol 1999; 246((Suppl 3))10–2
- Neilson S., Robinson I. Reinterpreting mortality statistics: some uses of Gompertzian analysis in epidemiological research. J Clin Epidemiol 1993; 46: 1063–9
- Neilson S., Robinson I., Clifford Rose F., Hunter M. Rising mortality from motor neuron disease: an explanation. Acta Neurol Scand 1993; 87: 184–91